SCOLR Pharma, Inc. To Present At The UBS Warburg Global Specialty Pharmaceuticals Conference On April 24, 2006

BELLEVUE, Wash.--(BUSINESS WIRE)--April 19, 2006--SCOLR Pharma, Inc. (Amex: DDD - News) announced today that Daniel O. Wilds, President and CEO of Scolr Pharma, will present at the UBS Global Specialty Pharmaceuticals Conference taking place at the Grand Hyatt in New York City. The presentation is scheduled for Monday, April 24, 2006 at 8:30am ET.
MORE ON THIS TOPIC